Enrolling by invitation NCT07106255
Task-oriented Training Intervention for Multiple Sclerosis Patients.
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Task-oriented training, Standar medical care and leaflet fatigue management.
- Who it may be relevant to
- Registry conditions: Multiple Sclerosis. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Spain
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Task-oriented Training Intervention for Multiple Sclerosis Patients
Overview
This study aims to evaluate the effectiveness of a Task-oriented program in improving functional performance and health outcomes in patients with Multiple Sclerosis.
Interventions
- Other Task-oriented training
Participants included in the experimental group will underwent an 8-week TOT intervention, administered twice weekly, with each session lasting 45 minutes. Within this framework, the intervention will comprise sessions involving meaningful and repetitive activities tailored to both the patient and their specific context. The occupations will be selected by each participant through the Canadian Occupational Performance Measure (COMP) tool in the initial assessment. The activities were randomly o - Other Standar medical care and leaflet fatigue management
Participants included in the control group will continue with their usual treatment and will receive a pamphlet containing information on fatigue management.
Primary outcome measures
- Occupational Performance [Time frame: Baseline and at 8 weeks at the end of the intervention, and through study completion, at 1, 3, 6, and 12 months post-intervention (an average of 1 year)]
Secondary outcome measures (1)
- Fatigue [Time frame: Baseline and at 8 weeks at the end of the intervention, and through study completion, at 1, 3, 6, and 12 months post-intervention (an average of 1 year)]
Eligibility criteria
Inclusion criteria
- Diagnosis of Multiple Sclerosis by a neurologist.
- Aged over 18 years old.
- Acceptance and signature of the informed consent.
Exclusion criteria
- A cognitive level or condition that did not allow completion of the evaluations.
- An exacerbation of MS during the previous 3 months.
- Presence of interfering musculoskeletal, neurological, orthopaedic, and/or rheumatic disorders affecting hand and/or finger mobility, including previous trauma or fracture of the upper extremity.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Spain · 1 center
- Faculty of Health Sciences. University of Granada — Granada
Identifiers
NCT: NCT07106255 · 036-N-23